2Ong AT, van DRT, Aoki J, el al. Sirolimus-eluting stents remain supe- rior to bare-metal stents at two years : medium-term results from the Ra- pamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital ( RESEARCH ) registry. J Am Coil Cardiol, 2006,47 : 1356-1360.
3Grube E, Dawkins K, Guagliumi G, et al. TAXUS VI final 5-year re- sults:a multicentre,randomised trial comparing polymer-based moder- ate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. Euro Intervention, 2009,4: 572-577.
4Serruys PW, Onuma Y, Garg S, et al, 5-year clinical outenmes of the ARTS II(Arterial Revaseularization Therapies Study II of the siroli- mus-eluting stent in the treatment of patients with multivessel de novo coronary altery lesions. J Am Coll Cardiol,2010,55:1093-1101.
5Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-elu- ting stents to prevent restenosis in diabetic patients. N Engl J Med, 2005,353 : 663 -670.
6Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and pa- clitaxel-eluting stents for coronary revascularization. N Engl J Med, 2005,353:653-662.
7Morice MC,Colombo A, Meier B, et al. Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions : the REALITY trial : a random- ized controlled trial. JAM A,2006,295 : 895-904.
8Cosgrave J, Melzi G, Corbett S,et al. Comparable clinical outcomes with paclitaxel-and siro|imus-eluting stents in unrestricted contempora- ry practice. J Am Coil Cardio1,2007 ,49 :2320-2328.
9Moses JW, Leon MB, Popma J J, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Eugl J Med ,2003,349 : 1315-1323.
10I.ee SW,Park SW, Kim YH, et al. A randomized comparison of siroli- mus-versus paclitaxel-eluting stent implantation in patients with diabe- tes mellitns 2-year clinical outcomes of the DES-DIABETES trial. J Am Coil Cardio1,2009,53:812-813.
